Rationale And Objective: The purpose of the study was to investigate a modified version of a so-called Perceptron algorithm in detecting focal liver lesions on CT scans.
Materials And Methods: The modified Perceptron algorithm is based on simulated annealing with a logarithmic cooling schedule and was implemented on a standard workstation. The algorithm was trained with 400 normal and 400 pathologic CT scans of the liver. An additional 100 normal and 100 pathologic scans were then used to test the detection of pathology by the algorithm. The total of 1000 scans used in the study were selected from the portal venous phase of upper abdominal CT examinations performed in patients with normal findings or hypovascularized liver lesions. The pathologic scans contained 1 to 4 focal liver lesions. For the preliminary version of the algorithm used in this study, it was necessary to define regions of interest that were converted to a matrix of 119 x 119.
Results: Training of the algorithm with 400 examples each of normal and abnormal findings took about 75 hours. Subsequently, the testing took several seconds for processing each scan. The diagnostic accuracy in discriminating scans with and without focal liver lesions achieved for the 200 test scans was approximately 99%. The error rate for pathologic and normal scans was comparable to results reported in the literature, which, however, were obtained for much smaller test sets.
Conclusion: The modified Perceptron algorithm has an accuracy of close to 99% in detecting pathology on CT scans of the liver showing either normal findings or hypovascularized focal liver lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2005.05.009 | DOI Listing |
Updates Surg
January 2025
University Center of Gastrointestinal and Liver Diseases-Clarunis, University of Basel, Basel, Switzerland.
Background: Primary hyperparathyroidism (PHPT) due to a parathyroid adenoma stands as one of the most prevalent endocrinological disorders, with focused parathyroidectomy being the established therapeutic strategy.
Aim: This study aims to investigate whether the volume of the pathological gland influences perioperative outcomes and postoperative morbidity.
Methods: A retrospective analysis was conducted on data from 141 patients who underwent focused parathyroidectomy for PHPT at the University Hospital of Basel between 2007 and 2022.
Eur J Nucl Med Mol Imaging
January 2025
Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Purpose: To evaluate the diagnostic accuracy and clinical impact of fibroblast activation protein (FAP)-targeted PET/CT imaging in primary and metastatic breast cancer and compare the results with those of standard-of-care imaging (SCI) and [F]FDG PET/CT.
Methods: We prospectively analyzed patients with diagnosed or suspected breast cancer who underwent concomitant FAP-targeted PET/CT (radiotracers including either [Ga]Ga-FAPI-46 or [F]FAPI-42) and [F]FDG PET/CT scans from June 2020 to January 2024 at two medical centers. Breast ultrasound (US) imaging was performed in all treatment-naïve patients as SCI.
Hepat Oncol
December 2024
Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
The aim of this study was to assess the utility of weighted amide proton transfer (APT) MRI in three different rodent models of hepatocellular carcinoma (HCC). APT MRI was evaluated in models of diethylnitrosamine (DEN) induced HCC, N1S1 syngeneic orthotopic xenograft and human HepG2 ectopic xenograft. All models of HCC showed a higher APT signal over the surrounding normal tissues.
View Article and Find Full Text PDFJ Exp Clin Cancer Res
January 2025
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Recent advances in oncology research have highlighted the promising synergy between low-dose radiation therapy (LDRT) and immunotherapies, with growing evidence highlighting the unique benefits of the combination. LDRT has emerged as a potent tool for stimulating the immune system, triggering systemic antitumor effects by remodeling the tumor microenvironment. Notably, LDRT demonstrates remarkable efficacy even in challenging metastatic sites such as the liver (uveal) and brain (cutaneous), particularly in advanced melanoma stages.
View Article and Find Full Text PDFBMC Med Imaging
January 2025
Department of Ultrasound Medicine, First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Background: Langerhans cell histiocytosis (LCH) is a rare disease, most prevalent in children. Ultrasound is a noninvasive, cheap, and widely available technique. However, systematic elucidation of sonographic features of LCH and treatment related follow-up are relatively few, resulting in overall underestimation of the clinical value of ultrasound in diagnosing and monitoring LCH.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!